• Most Popular
  • Most Shared

UPDATE 1-Warner Chilcott Q3 profit tops estimates, ups '08 view

Mon Nov 10, 2008 8:08am EST

Stocks

   

* Q3 Cash EPS $0.39 beats estimates by $0.06

Stocks

* Rev of $231.9 mln slightly below expectations

* Raises '08 Cash EPS view by $0.08/shr

* Backs rev outlook for 2008

Nov 10 (Reuters) - Warner Chilcott Ltd (WCRX.O) reported a quarterly profit that topped market expectations, helped by strong sales of its oral contraceptive and dermatology products, and raised its 2008 earnings outlook on lower cost estimates.

Net income for the third quarter was $40.1 million, compared with $5.8 million a year earlier.

Net sales of oral contraceptive Loestrin 24 FE and Femcon FE rose 33 percent and 21 percent respectively, while dermatology product sales rose 16 percent. Sales of Doryx acne treatment soared 53 percent.

Shares of the company closed at $13.40 Friday on Nasdaq.

For the press release, please click [ID:nPnNY44901] . For the alerts, please click [ID:nWNAB0800] (Reporting by Esha Dey in Bangalore; Editing by Amitha Rajan)

Stocks


More from Reuters

Photo

Developing nations slam U.S.-led climate deal

COPENHAGEN (Reuters) - Several developing nations rejected on Saturday a climate deal worked out by President Barack Obama and four major emerging economies, saying it could not become a U.N. blueprint for fighting global warming. | Video

» More Top News
A woman shops at a Sam's Club store, a division of Wal-Mart Stores, in Bentonville, Arkansas June 4, 2009. REUTERS/Jessica Rinaldi

The food-stamp economy

On the last day of every month, shoppers at Walmart load their carts with food and household items and wait for the midnight hour. Is this the new normal in America?  Full Article 

U.S.
Two men shake hands in a file photo. REUTERS/File

Let's make a deal

The battered M&A sector will make a tepid recovery in the coming year and three hot sectors will lead the way, according to a Thomson Reuters analysis.  Full Article 

Global Deals Review